Ilja F. Ciernik

Dessau, ST, DE 
Dessau, ST, DE 

Overview

Ilja Ciernik practices practicing medicine in Dessau, Germany.

Their clinical expertise encompasses Melanoma of the Eye, Uveal Melanoma, Lacrimal Gland Tumor, Melanoma, and Mastectomy.

They are actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 1 clinical trial.

Locations

Dessau, ST, Germany
Other Locations
Halle, NI, Germany
Bonn, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone
Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug, Radiation
Study Drugs: Gemcitabine, FOLFIRINOX
Study Phase: Phase 3

26 Total Publications

O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial.
O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial.
Journal: The Lancet. Oncology
Published: August 19, 2025

Frequently Asked Questions about Ilja F. Ciernik

Is Ilja F. Ciernik a top-rated expert for Melanoma of the Eye?

MediFind is an objective health platform that identifies experts based on real-world data. Ilja F. Ciernik is classified as an Experienced expert for Melanoma of the Eye, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ilja F. Ciernik participate in research or clinical trials?

Yes. Ilja F. Ciernik has published 26 articles and abstracts on conditions like Melanoma of the Eye. You can view a list of Ilja F. Ciernik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ciernik's expertise for a condition
ConditionClose
        View All 16 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile